Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03848702
Previous Study | Return to List | Next Study

Nonoperative Treatment of Dorsally Dislocated Distal Radius Fractures in Adults With an Individualized 3D Printed Brace.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03848702
Recruitment Status : Completed
First Posted : February 21, 2019
Last Update Posted : February 22, 2019
Sponsor:
Collaborator:
Erasmus Medical Center
Information provided by (Responsible Party):
VieCuri Medical Centre

Brief Summary:

Study design: Two consecutive prospective case series. Study population: Part 1 will enroll 10 healthy volunteers (50 years or older). Part 2 will enroll 10 elderly patients (50 years or older) with a dorsally displaced distal radius fracture (AO type 23-A-C) that is acceptably reduced. In both parts, participants should have no restrictions in activities of daily living pre-fracture and no evident anatomical difference between both wrists.

Intervention:

Part 1: Participants will wear the brace continuously for one week. Part 2: Participants will wear the brace as treatment of the fracture for five weeks (instead of a plaster cast).

Main study parameters/endpoints: In parts 1 and 2, the primary outcome measure will be a Visual Analog Scale (VAS) score for wearing comfort. Secondary outcome measures are the occurrence of fracture redislocation (part 2 only), pain (VAS), inconvenience during NL61002.078.17 / DRFB-Tolerability Distal Radius Fracture Brace Tolerability Version number: 1.1, d.d. April 24, 2017 8 of 34 activities of daily living (Katz Index), and adverse reactions like pain, skin pressure, skin irritation/redness, sensibility issues, or device-related problems.


Condition or disease Intervention/treatment Phase
Dorsal Displacement Device: Distal radius fracture brace Not Applicable

Detailed Description:

Rationale: Each year, approximately 34,500 adults in The Netherlands sustain a fracture of the distal radius (wrist fracture). Incidence peaks in the elderly. The currently preferred treatment is closed reduction and nonoperative treatment by immobilization in a plaster cast for 4-6 weeks. Surgery is only performed if closed reduction fails or redislocation occurs. Plaster immobilization is inconvenient and interferes with daily activities. More importantly, standard nonoperative treatment often fails; in 40-60% of the fractures, redislocation requires surgery. Surgical treatment is about 9 times more expensive than nonoperative treatment and not without risks. This project aims to develop an innovative nonoperative treatment option. The central idea is to produce a 3D-printed brace for the fractured wrist using a mirrored CT-scan of the contralateral, unfractured wrist as a model. This innovative approach has the advantage that it does not depend on surgery and provides a better and potentially more durable positioning than the currently applied plaster cast. We expect that redislocation will occur less frequently, so surgery may be avoided. In contrast to a traditional plaster cast, the newly developed brace is water resistant/repellant, lighter, and enables movement of the hand. It enables daily activities and improves independency in the elderly with a wrist fracture. The treatment has been successfully evaluated in an ex vivo model. The clinical implementation will follow a step-wise approach.

Objective: Part 1 aims to determine the tolerability of the 3D-printed brace when worn by healthy volunteers (50 years of order), performing their normal daily activities. In part 2, the objective is to determine tolerability of the 3D-printed brace in patients (50 years or older) with an extra-articular distal radius fracture with dorsal displacement, performing their normal daily activities.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Two consecutive prospective case series to investigate brace feasibility.
Masking: Double (Participant, Care Provider)
Masking Description: For part 1, a randomization list will be generated using an online program. For the 10 participants, five braces will be developed for the dominant side and five for the nondominant side. The physician and participant will be concealed for allocated side until the scan will be made.
Primary Purpose: Other
Official Title: Nonoperative Treatment of Dorsally Dislocated Distal Radius Fractures in Adults With an Individualized 3D Printed Brace; a Tolerability Study in Healthy Volunteers and Patients (DRFB)
Actual Study Start Date : July 1, 2017
Actual Primary Completion Date : June 1, 2018
Actual Study Completion Date : July 1, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Healthy volunteers
All volunteers wore the DRFB
Device: Distal radius fracture brace
The distal radius fracture brace is constructed from biocompatible materials (like polylactic acid; PLA) and the skin is protected by commercially available and approved waterproof padding (like Aquacast®). The major brace components are connected and reinforced with carbon rods and plastic bolt-nut connections. PLA is extensively used, for example in surgical implants, but also as biological alternative for plastics. Aquacast® is approved and used as waterproof padding in swim plaster. The biomechanical function of the distal radius brace has been tested successfully in an ex vivo setting (results to be published). The DRFB includes the distal forearm, wrist an base of the hand. The thumb and fingers are free and the DRFB provides more movement than classical casting.

Experimental: Patients with DRF
All patients wore the DRFB
Device: Distal radius fracture brace
The distal radius fracture brace is constructed from biocompatible materials (like polylactic acid; PLA) and the skin is protected by commercially available and approved waterproof padding (like Aquacast®). The major brace components are connected and reinforced with carbon rods and plastic bolt-nut connections. PLA is extensively used, for example in surgical implants, but also as biological alternative for plastics. Aquacast® is approved and used as waterproof padding in swim plaster. The biomechanical function of the distal radius brace has been tested successfully in an ex vivo setting (results to be published). The DRFB includes the distal forearm, wrist an base of the hand. The thumb and fingers are free and the DRFB provides more movement than classical casting.




Primary Outcome Measures :
  1. VAS score [ Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 ]
    the primary outcome measure will be the change in 1 week (part 1) and over several weeks (part 2) on a 10-centimeter Visual Analog Scale (VAS) score for wearing comfort, in which 0 implies no comfort. and 10 implies extremely comfortable.


Secondary Outcome Measures :
  1. Redislocation [ Time Frame: Week 1, week 2 and week 5 (only part 2) ]

    Redislocation is determined by the radiologic outcome:

    • Dorsal tilt > 15˚ on lateral X-ray
    • Volar tilt >20˚ on lateral X-ray
    • Shortening >5mm pertaining to the ulna in PA direction
    • Intraarticular step-off ≥ 2mm
    • Radial inclination < 15˚ in PA direction
    • Subluxation of the lunate According to guidelines on these parameters, redislocation is diagnosed.

  2. Pain Level [ Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 ]
    Pain level caused by the brace will be determined using a 10-centimeter Visual Analog Scale (VAS), in which 0 implies no pain and 10 implies the worst possible pain.

  3. Inconvenience [ Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 ]
    Inconvenience during activities of daily living using the Katz Index. The Katz Index asks for limitations in washing, clothing, indoor transfers, toilet visit, continence and eating. The range for the Katz index is 0 to 6 where 6 indicates full function, 4 indicates moderate impairment and 2 or less indicates severe functional impairment.

  4. Adverse reactions (pain, skin pressure, skin irritation/redness, sensibility issues or device-related problems [ Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2 ]
    Adverse reactions like pain, skin pressure, skin irritation/redness, sensibility issues, or device-related problems.


Other Outcome Measures:
  1. Age (calculated from date of birth and date of enrolment) [ Time Frame: At baseline ]
    - Age (calculated from date of birth and date of enrolment)

  2. Gender [ Time Frame: At baseline ]
    - Gender (male or female)

  3. ASA class [ Time Frame: At baseline ]
    - ASA class (1, 2, 3 of 4), assessed in a face-to-face interview

  4. BMI (calculated from height and weight) [ Time Frame: At baseline ]
    - BMI (calculated from height and weight)

  5. Tobacco consumption [ Time Frame: At baseline ]
    - Tobacco consumption (current, ever, never) was assessed in a short face-to-face interview

  6. Alcohol consumption [ Time Frame: At baseline ]
    - Alcohol consumption at enrolment (yes or no), assessed in a face-to-face interview

  7. Comorbidities including osteoporosis [ Time Frame: At baseline ]
    - Comorbidities including osteoporosis were assessed from the electronic patients dossiers

  8. Medication use [ Time Frame: At baseline ]
    Medication use was assessed through the electronic patient dossiers

  9. Dominant side (left or right) [ Time Frame: At baseline ]
    Dominant side was assessed in a face-to-face interview

  10. Affected side (part 2 only) [ Time Frame: At baseline ]
    - Affected side (left or right) was assessed by the clinician

  11. Trauma mechanism (low energy/high energy trauma or unknown) [ Time Frame: At baseline ]
    - Trauma mechanism (low energy fall or other, high energy trauma, or unknown) was assessed through face-to-face interview

  12. Additional injuries (yes or no, with specification) [ Time Frame: At baseline ]

    Additional injuries were assessed in a face-to-face interview

    • Trauma mechanism (low energy fall or other, high energy trauma, or unknown)
    • Additional injuries (yes or no, with specification)
    • Fracture classification (AO type 23-A, B or C)

  13. Fracture classification (AO type 23-A, B or C) [ Time Frame: At baseline ]
    - Fracture classification (AO type 23-A, B or C) was diagnosed by the clinician

  14. Date of scanning [ Time Frame: At baseline ]
    Date of scanning was documented by the clinician

  15. Date of brace fitting [ Time Frame: At baseline ]
    Date of brace fitting was documented by the clinician.

  16. Date of brace removal [ Time Frame: At baseline ]
    Date of brace removal was documented by the clinician. If brace was removed early, it was documented how treatment was continued (in patients only).

  17. Adherence to intervention [ Time Frame: At baseline ]
    Adherence to the intervention was checked (yes/no) and reasons for not adhering were documented by the clinician



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Part 1:

  1. Age 50 years or older
  2. Healthy volunteer without distal radius fracture
  3. No restrictions in activities of daily living prior to enrolment*
  4. Signed informed consent by participant * Participant should exercises complete self-control over urination and defecation, but use of incontinence material is allowed.

Part 2:

  1. Patients (50 years or older) with an acute**, unilateral distal radius fracture with dorsal displacement (AO type 23-A, B, or C) that is acceptably reduced (by simple closed reduction with vertical longitudinal traction)
  2. No restrictions in activities of daily living pre-fracture*
  3. Signed informed consent by patient

    • Participant should exercises complete self-control over urination and defecation, but use of incontinence material is allowed. ** Patients should report to the Emergency Department within 48h post-trauma.

Exclusion Criteria:

Part 1:

  1. Preexisting anatomical deviation of the ipsi- or contralateral wrist
  2. Conditions that affect function of the wrist or hand
  3. Insufficient comprehension of the Dutch or language to understand the study documents
  4. Participant unwilling or unable to comply with the study protocol and follow-up visit schedule
  5. Known allergy for brace material (PLA or alternative)

Part 2:

  1. Preexisting anatomical deviation of the ipsi- or contralateral wrist
  2. Additional traumatic injuries that affect treatment, rehabilitation, or function of the affected hand
  3. Pathological, recurrent, or open fracture
  4. Impaired wrist function pre-trauma at either wrist (e.g., arthrosis, rheumatoid disorder, or neurological disorder)
  5. Bone disorder that may impair bone healing, excluding osteoporosis
  6. Patient unwilling or unable to comply with the treatment protocol and follow-up visit schedule
  7. Insufficient comprehension of the Dutch language to understand the study documents
  8. Known allergy for brace material (PLA or alternative).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03848702


Locations
Layout table for location information
Netherlands
VieCuri MC
Venlo, Limburg, Netherlands, 5912 BL
Sponsors and Collaborators
VieCuri Medical Centre
Erasmus Medical Center
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: VieCuri Medical Centre
ClinicalTrials.gov Identifier: NCT03848702    
Other Study ID Numbers: Nl61002.078.17
First Posted: February 21, 2019    Key Record Dates
Last Update Posted: February 22, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Radius Fractures
Forearm Injuries
Arm Injuries
Wounds and Injuries
Fractures, Bone